Pembrolizumab plus Chemotherapy in Lung Cancer
N Engl J Med
.
2018 Sep 13;379(11):e18.
doi: 10.1056/NEJMc1808567.
Authors
Ryan Sun
1
,
Michael W Rich
2
,
Lee-Jen Wei
1
3
Affiliations
1
Harvard T.H. Chan School of Public Health, Boston, MA
2
Washington University School of Medicine, St. Louis, MO
3
[email protected]
PMID:
30211499
DOI:
10.1056/NEJMc1808567
No abstract available
Publication types
Letter
Comment
MeSH terms
Antibodies, Monoclonal, Humanized*
Carcinoma, Non-Small-Cell Lung
Humans
Lung Neoplasms*
Substances
Antibodies, Monoclonal, Humanized
pembrolizumab